Moncef Slaoui, who left the drugmaker in 2017 and has worked as a venture capitalist, will help coordinate the development of Covid-19 vaccines.
Moncef Slaoui, who left the drugmaker in 2017 and has worked as a venture capitalist, will help coordinate the development of Covid-19 vaccines.